Related Experiment Video
Updated: May 28, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Role for p53 in selenium-induced senescence
Min Wu1, Ryan T Y Wu, Thomas T Y Wang
1Department of Nutrition and Food Science, University of Maryland, College Park, Maryland 20742, United States.
Abstract:
The tumor suppressor p53 and the ataxia-telangiectasia mutated (ATM) kinase play important roles in the senescence response to oncogene activation and DNA damage. It was previously shown that selenium-containing compounds can activate an ATM-dependent senescence response in MRC-5 normal fibroblasts. Here, the shRNA knockdown approach and other DNA damage assays are employed to test the hypothesis that p53 plays a role in selenium-induced senescence. In MRC-5 cells treated with methylseleninic acid (MSeA, 0-10 μM), depletion of p53 hampers senescence-associated expression of β-galactosidase, disrupts the otherwise S and G2/M cell cycle arrest, desensitizes such cells to MSeA treatment, and increases genome instability. Pretreatment with KU55933, an ATM kinase inhibitor, or NU7026, an inhibitor of DNA-dependent protein kinase, desensitizes MSeA cytotoxicity in scrambled but not p53 shRNA MRC-5 cells. These results suggest that p53 is critical for senescence induction in the response of MRC-5 noncancerous cells to selenium compounds.
Insights
The tumor suppressor p53 is crucial for selenium-induced cell senescence in normal fibroblasts. Depleting p53 disrupts cell cycle arrest and increases genome instability, highlighting its critical role in this process.
Area of Science:
- Cellular senescence
- DNA damage response
- Cancer prevention
Background:
- Tumor suppressor p53 and ATM kinase are key in senescence.
- Selenium compounds activate ATM-dependent senescence in fibroblasts.
- The role of p53 in selenium-induced senescence requires further investigation.
Purpose of the Study:
- To investigate the role of p53 in selenium-induced senescence.
- To determine if p53 is essential for the senescence response to methylseleninic acid (MSeA).
Main Methods:
- shRNA knockdown to deplete p53 in MRC-5 cells.
- Methylseleninic acid (MSeA) treatment to induce senescence.
- Assays for senescence markers (β-galactosidase), cell cycle arrest, and genome instability.
- Inhibition of ATM and DNA-PK kinases.
Main Results:
- p53 depletion reduced senescence markers and disrupted cell cycle arrest (S and G2/M phases).
- p53-depleted cells showed increased sensitivity to MSeA and heightened genome instability.
- ATM and DNA-PK inhibitors reduced MSeA cytotoxicity in control cells but not in p53-depleted cells.
Conclusions:
- p53 is essential for inducing senescence in response to selenium compounds in MRC-5 cells.
- The p53 pathway is critical for mediating the anti-cancer effects of selenium.
- These findings underscore the importance of p53 in cellular defense mechanisms against genotoxic stress.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Replicative Cell Senescence
Replicative Cell Senescence
